Simon Beaulah, SVP Healthcare at PrecisionLife is attending the Pharma Partnering Summit USA in Boston to partner with companies innovating to develop better, more personalized treatments for areas of unmet medical need.
Our scalable platform has delivered the deepest disease insights in over 40 complex, chronic indications, and a drug discovery pipeline of IP in the form of over 300 novel drug targets and precision drug repositioning opportunities for multiple conditions with compelling unmet medical needs. These insights are protected and derisked by our unique and highly specific patient stratification biomarkers and available for partnering.
To explore partnering opportunities with us, meet with Simon at the Pharma Partnering Summit or contact us.